Antidepressant Reduces Likelihood That High-Risk Patients With COVID-19 Will Be Hospitalized, Study Indicates

The New York Times (10/27, Mueller) reports, “A large clinical trial has found that” fluvoxamine, “a common and inexpensive antidepressant, lowered the odds that high-risk” patients with “Covid-19...would be hospitalized.” The findings (10/28) were publis...